Longeveron (LGVN) Other Working Capital Changes (2020 - 2026)
Longeveron's (LGVN) quarterly Other Working Capital Changes came in at $11000.0 in Q1 2026, down 82.81% year-on-year from $64000.0 in Q1 2025, and down 82.54% quarter-over-quarter from $63000.0 in Q4 2025.
Longeveron (LGVN) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Longeveron's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $11000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 82.81% year-over-year to $11000.0 in Q1 2026; TTM through Mar 2026 was $201000.0, a 21.18% decrease from a year earlier, with the FY2025 full-year figure at $254000.0, changed 0.0% from the prior year.
- Other Working Capital Changes slipped to $11000.0 in Q1 2026 per LGVN's latest filing, from $63000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $912000.0 in Q1 2024 and bottomed at -$901000.0 in Q2 2024.
- The 5-year median for Other Working Capital Changes is -$1000.0 (2024), against an average of -$2294.1.
- Across the five-year window, Other Working Capital Changes grew 25.49% in 2024 and slumped 82.81% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at $64000.0 in 2023, then decreased by 1.56% to $63000.0 in 2024, then changed by 0.0% to $63000.0 in 2025, then slumped by 82.54% to $11000.0 in 2026.
- Per Business Quant, the three latest LGVN Other Working Capital Changes figures stand at $11000.0 (Q1 2026), $63000.0 (Q4 2025), and $64000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Mar 31, 2025 | 610,000.00 |
| Mar 31, 2025 | 610,000.00 |
| Mar 31, 2025 | 610,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |